The estimated Net Worth of Brian K Hutchison is at least 1.36 百万$ dollars as of 13 May 2015. Brian Hutchison owns over 92,253 units of RTI Surgical stock worth over 1,364,054$ and over the last 21 years Brian sold RTIX stock worth over 0$.
Sign up
Brian Hutchison RTIX stock SEC Form 4 insiders trading
Brian has made over 6 trades of the RTI Surgical stock since 2003, according to the Form 4 filled with the SEC. Most recently Brian exercised 92,253 units of RTIX stock worth 570,124$ on 13 May 2015.
The largest trade Brian's ever made was exercising 100,000 units of RTI Surgical stock on 8 August 2005 worth over 480,000$. On average, Brian trades about 8,683 units every 156 days since 2003. As of 13 May 2015 Brian still owns at least 434,412 units of RTI Surgical stock.
You can see the complete history of Brian Hutchison stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Brian Hutchison's mailing address?
Brian's mailing address filed with the SEC is C/O REGENERATION TECHNOLOGIES INC, 1162 RESEARCH CIRCLE, ALACHUA, FL, 32615.
Insiders trading at RTI Surgical
Over the last 21 years, insiders at RTI Surgical have traded over 71,830$ worth of RTI Surgical stock and bought 390,515 units worth 1,973,594$ . The most active insiders traders include Jeffrey C Lightcap、Mark Stolper、Terry M. Rich. On average, RTI Surgical executives and independent directors trade stock every 138 days with the average trade being worth of 62,561$. The most recent stock trade was executed by Jonathon M Singer on 12 December 2018, trading 50,000 units of RTIX stock currently worth 214,000$.
What does RTI Surgical do?
RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.
What does RTI Surgical's logo look like?
Complete history of Brian Hutchison stock trades at RTI Surgical
RTI Surgical executives and stock owners
RTI Surgical executives and other stock owners filed with the SEC include:
-
Jonathon Singer,
Chief Financial Officer, Chief Operating Officer -
John Varela,
Executive Vice President - Global Operations -
Olivier Visa,
Vice President - OEM, Sports and Donor Services -
Shirley Weis,
Independent Director -
Thomas McEachin,
Independent Director -
Mark Stolper,
Lead Independent Director -
Paul Thomas,
Independent Director -
Nicholas Valeriani,
Independent Director -
Pawel Lewicki,
Director -
Scott Durall,
Chief Commercial Officer -
Bryan Cornwall,
Executive Vice President - Research and Clinical Affairs -
Stuart Simpson,
Chairman of the Board -
Molly Poarch,
Director, Corporate Communications & Investor Relations -
Jeffrey Lightcap,
Independent Director -
Brian Kushner,
Director -
Ryan Bartolucci,
Vice President - Finance, Corporate Controller -
Terry Rich,
President, Chief Executive Officer, Director -
Lyle P. Luedeman,
-
Dean H Bergy,
Director -
Street Healthcare Partners ...,
-
Christopher R Sweeney,
Director -
Curtis M Selquist,
Director -
Peter F Gearen,
Director -
Brian K Hutchison,
Chairman, President and CEO -
Camille Farhat,
Chief Executive Officer -
Robert P Jordheim,
Executive Vice President/CFO -
Roger W Rose,
Vice President Donor Services -
Johannes Wynand Louw,
Vice President Finance -
Kevin D Brandt,
EVP CCO-Domestic Direct -
Joshua H De Rienzis,
General Counsel -
Philip R Chapman,
Director -
Ned Hoye Villers,
Director -
Adrian J R Smith,
Director -
Caroline A Hartill,
V.P. Quality Assurance -
Julianne M Bowler,
Director -
Roy D Crowninshield,
Director -
Gregory P Rainey,
Director -
Neal B Freeman,
Director -
Michael J La Prade,
Vice President -
Holdings Inc Zimmer,
10% owner -
Roderick N Allen,
Vice President -
David J Simpson,
Director -
Guy L Mayer,
President -
Michael J Odrich,
Director -
Lee Robert Jr Johnston,
Vice President -
Udo Henseler,
Director -
Christie J Blakely,
Vice President -
Robert J Lane,
Vice President -
Tara Leigh Zerby,
VP, Xenograft Technologies -
Carolyn Shaffer,
Vice President, Human Resource -
Thomas F Rose,
Vice President and CFO -
Michael T Manley,
Director -
Louis E Barnes,
Vice President-Cardiovascular -
Charles Randal Mills,
V.P. of Business Development -
William Melendez,
Vice President, Research & Dev -
Jeffrey Michael Schumm,
Vice Pres. and General Counsel -
Joseph W Condon,
Vice President-Operations